MediPharm Labs Corp. (TSX:LABS)

MediPharm Labs Statistics

Total Valuation

MediPharm Labs has a market cap or net worth of CAD 33.99 million. The enterprise value is 24.14 million.

Market Cap	33.99M
Enterprise Value	24.14M

Important Dates

The last earnings date was Wednesday, May 13, 2026.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

MediPharm Labs has 424.86 million shares outstanding. The number of shares has increased by 2.41% in one year.

Current Share Class	424.86M
Shares Outstanding	424.86M
Shares Change (YoY)	+2.41%
Shares Change (QoQ)	+0.75%
Owned by Insiders (%)	9.16%
Owned by Institutions (%)	0.00%
Float	385.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.79
PB Ratio	0.97
P/TBV Ratio	0.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.76
EV / Sales	0.56
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.15

Financial Position

The company has a current ratio of 3.02, with a Debt / Equity ratio of 0.00.

Current Ratio	3.02
Quick Ratio	1.92
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-124.03

Financial Efficiency

Return on equity (ROE) is -22.33% and return on invested capital (ROIC) is -30.83%.

Return on Equity (ROE)	-22.33%
Return on Assets (ROA)	-10.05%
Return on Invested Capital (ROIC)	-30.83%
Return on Capital Employed (ROCE)	-21.91%
Weighted Average Cost of Capital (WACC)	9.67%
Revenue Per Employee	340,795
Profits Per Employee	-68,874
Employee Count	127
Asset Turnover	0.90
Inventory Turnover	3.27

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.29% in the last 52 weeks. The beta is 0.96, so MediPharm Labs's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	+14.29%
50-Day Moving Average	0.07
200-Day Moving Average	0.07
Relative Strength Index (RSI)	50.65
Average Volume (20 Days)	521,374

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MediPharm Labs had revenue of CAD 43.28 million and -8.75 million in losses. Loss per share was -0.02.

Revenue	43.28M
Gross Profit	12.54M
Operating Income	-7.69M
Pretax Income	-8.75M
Net Income	-8.75M
EBITDA	-6.11M
EBIT	-7.69M
Loss Per Share	-0.02

Balance Sheet

The company has 9.87 million in cash and 18,000 in debt, with a net cash position of 9.85 million or 0.02 per share.

Cash & Cash Equivalents	9.87M
Total Debt	18,000
Net Cash	9.85M
Net Cash Per Share	0.02
Equity (Book Value)	35.10M
Book Value Per Share	0.08
Working Capital	17.21M

Cash Flow

In the last 12 months, operating cash flow was -3.32 million and capital expenditures -59,000, giving a free cash flow of -3.38 million.

Operating Cash Flow	-3.32M
Capital Expenditures	-59,000
Depreciation & Amortization	1.58M
Net Borrowing	-111,000
Free Cash Flow	-3.38M
FCF Per Share	-0.01

Margins

Gross margin is 28.97%, with operating and profit margins of -17.77% and -20.21%.

Gross Margin	28.97%
Operating Margin	-17.77%
Pretax Margin	-20.21%
Profit Margin	-20.21%
EBITDA Margin	-14.11%
EBIT Margin	-17.77%
FCF Margin	n/a

Dividends & Yields

MediPharm Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.41%
Shareholder Yield	-2.41%
Earnings Yield	-25.73%
FCF Yield	-9.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2